Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens (NCT05216510) | Tonix Pharmaceuticals, Inc. | 2022-01-07 |
Track Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2 automatically
Every clearance here is in the API, with alerts when new ones post.